HFR Freiburg-Kantonsspital

Fribourg 1752

2 studies enrolling now · 2 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, HER2 Mutation, Metastatic Non-small Cell Lung Cancer

Studies at this site

• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC — Recruiting now